Progress in the Development of Antitissue Factor Pathway Inhibitors for Haemophilia Management
dc.citation.doi | 10.3389/FMED.2021.670526 | |
dc.citation.epage | 5 | |
dc.citation.spage | 1 | |
dc.contributor.author | Johnny Mahlangu | |
dc.date.accessioned | 2023-04-13T10:23:14Z | |
dc.date.available | 2023-04-13T10:23:14Z | |
dc.identifier.citation | WOS | |
dc.identifier.issn | ****-**** | |
dc.identifier.uri | https://hdl.handle.net/10539/35009 | |
dc.journal.title | FRONTIERS IN MEDICINE | |
dc.journal.volume | 8 | |
dc.title | Progress in the Development of Antitissue Factor Pathway Inhibitors for Haemophilia Management |
Files
Original bundle
1 - 1 of 1